Identifying a Subgroup of High-Risk Prostate Cancer Patients With Worse Clinical Outcomes: Should There Be a "Very High-Risk" Group?

被引：0
|
作者：
Choi, S. [1 ]
Levy, L. B. [1 ]
Lee, K. K. [1 ]
Nguyen, Q. N.
Lee, A. K. [2 ,3 ]
McGuire, S. E. [1 ]
Kudchadker, R. [1 ]
Du, W. [1 ]
Hoffman, K. E. [1 ]
Mahmood, U. [1 ]
Frank, S. J. [1 ]
Kuban, D. A. [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Div Radiat Oncol, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX 77030 USA
[3] Texas Ctr Proton Therapy, Irving, TX USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2016年 / 96卷 / 02期
关键词：
D O I：
10.1016/j.ijrobp.2016.06.1228
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2586
引用
收藏
页码：E240 / E241
页数：2
相关论文
共 50 条
  • [21] Survival after Radical Prostatectomy versus Radiation Therapy in High-Risk and Very High-Risk Prostate Cancer
    Montorsi, Francesco
    Mazzone, Elio
    Gandaglia, Giorgio
    Stabile, Armando
    Salonia, Andrea
    Briganti, Alberto
    JOURNAL OF UROLOGY, 2022, 208 (01): : 223 - 224
  • [22] Interim Outcomes of a High-dose Whole Pelvic IMRT for Very High-risk Group of Patients With Locally Advanced Prostate Cancer
    Mizowaki, T.
    Norihisa, Y.
    Ogura, M.
    Takayama, K.
    Kamba, T.
    Inoue, T.
    Shimizu, Y.
    Kamoto, T.
    Ogawa, O.
    Hiraoka, M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S360 - S360
  • [23] Predicting High-Risk Patients and High-Risk Outcomes in Heart Failure
    Wehbe, Ramsey M.
    Khan, Sadiya S.
    Shah, Sanjiv J.
    Ahmad, Faraz S.
    HEART FAILURE CLINICS, 2020, 16 (04) : 387 - 407
  • [24] IDENTIFYING PATIENTS WITH HIGH-RISK OF HIGH COST
    TERES, D
    RAPOPORT, J
    CHEST, 1991, 99 (03) : 530 - 531
  • [25] National Cooperative Group Trials of "High-Risk" Patients With Lung Cancer: Are They Truly "High-Risk"?
    Puri, Varun
    Crabtree, Traves D.
    Bell, Jennifer M.
    Kreisel, Daniel
    Krupnick, Alexander S.
    Broderick, Stephen
    Patterson, G. Alexander
    Meyers, Bryan F.
    ANNALS OF THORACIC SURGERY, 2014, 97 (05): : 1678 - 1683
  • [26] Feasibility of IMRT plus regional hyperthermia for high-risk and very high-risk prostate carcinoma
    Nakahara, S.
    Ohguri, T.
    Yahara, K.
    Tomura, K.
    Kakinouchi, S.
    Korogi, Y.
    RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S852 - S852
  • [27] Should smokers be considered a high-risk group for colorectal cancer?
    Giovannucci, E
    DIGESTIVE AND LIVER DISEASE, 2004, 36 (10) : 643 - 645
  • [28] Oncological results of neoadjuvant chemohormonal therapy in patients with high and very high-risk prostate cancer
    Berkut, M., V
    Artemjeva, A. S.
    Reva, S. A.
    Tolmachev, S. S.
    Petrov, S. B.
    Nosov, A. K.
    ONKOUROLOGIYA, 2020, 16 (01): : 54 - 63
  • [29] Re: Survival After Radical Prostatectomy Versus Radiation Therapy in High-risk and Very High-risk Prostate Cancer
    Pushkar, Dmitry
    Govorov, Alexander
    EUROPEAN UROLOGY, 2022, 82 (01) : 144 - 145
  • [30] Cancer risk in systemic sclerosis: identifying risk and managing high-risk patients
    Fragoulis, George E.
    Daoussis, Dimitris
    Pagkopoulou, Eleni
    Garyfallos, Alexandros
    Kitas, George D.
    Dimitroulas, Theodoros
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2020, 16 (12) : 1105 - 1113
12345